- What factors are behind the size of remittances2015 | Faculty of Science
- Moldova and social remittances: the consequences of emigration for the society2019 | Faculty of Science
- Survey of Foreigners' Incomes, Expenditures and RemittancesPublication without faculty affiliation
- Ukrainian labour migrants in Czechia2015 | Faculty of Social Sciences, Faculty of Science, Faculty of Arts
- Not only Money, but the Integration and Loyalty of Migrants: Proposals for further Study of the Remittances sent from the Czech Republic2010 | Publication without faculty affiliation
- Labour Migration and Remittances: Current Trends in Times of Economic Recession2011 | Faculty of Science
- How much do foreign migrants earn and for whom is it an asset? Migration-development-remittances and Ukrainians in Czechia2013 | Faculty of Science
- The birth and the importance of remittances in the management of migrants in the destination country (Example Ukrainian immigrants in Prague)2015 | Faculty of Science
- Remittances and methods of their measurement: Case study of Czechia2015 | Faculty of Science
- Remittances and their development impact2011 | Faculty of Social Sciences
- Migration instead of aid? Remittances and brain circulation as tools of development2008 | Faculty of Science
- Treatment of relapsing-remitting multiple sclerosis2008 | First Faculty of Medicine
- "Migration-remittances-development": reality and theoretical-methodological framework of the paradigm2015 | Faculty of Science
- Ofatumumab - a highly effective therapy for relapsing-remitting multiple sclerosis available in the first line2022 | Faculty of Medicine in Hradec Králové
- Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients2016 | First Faculty of Medicine
- Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis2022 | Second Faculty of Medicine
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | First Faculty of Medicine
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | First Faculty of Medicine
- Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis2017 | First Faculty of Medicine
- Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study2016 | First Faculty of Medicine
- Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review2017 | First Faculty of Medicine
- Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase2020 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years : A Longitudinal Study2013 | First Faculty of Medicine
- Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis2023 | Faculty of Physical Education and Sport
- Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis2014 | First Faculty of Medicine
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | Second Faculty of Medicine
- Sentimental Money - What Is the Cost of Transnational Motherhood?2019 | Faculty of Science, Faculty of Humanities
- Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis2021 | Publication without faculty affiliation
- Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years2020 | First Faculty of Medicine
- Migrant remitting as transnational practice: Moldovans in Italy and Czechia2021 | Faculty of Science
